Crohn's disease (CD) is a chronic inflammatory disease involving the gastrointestinal tract with symptoms such as abdominal pain, chronic diarrhoea, weight loss and fatigue typically. 1 Although CD symptoms manifest in a relapsing and remitting manner, it is still a progressive disease, leading to bowel damage and disability. 1 Although the cause and pathophysiology of CD remain unclear, it is believed to result from the interaction among genetic susceptibility, environmental factors and intestinal microflora, leading to an abnormal mucosal immune response and defective epithelial barrier. 1 Many autophagy-related genes, including NOD2, ATG16L1, IRGM, LRRK2 and XBP1, which also exert various effects on Paneth cells, were reported to be involved in IBD pathogenesis. Autophagy implies any cellular degradative pathway that delivers cytoplasmic cargo to lysosomes. 2 Through autophagy, damaged organelles as well as invading bacteria can be engulfed by autophagosomes and sent to lysosomes for degradation, which is necessary for the activation of innate immunity. 3 In addition to non-selective degradation, autophagy can also selectively degrade specific targets. For example, NOD2 can specifically identify anti-microbial peptides (AMPs) in PC vesicles and release them into the intestinal lumen instead of degradation.